|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Benign Prostatic Hyperplasia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hyperplasia | |||||
| Prostatic Hyperplasia | |||||
| 3 | More general conditions related to this trial | ||||
| Genital Diseases, Male | |||||
| Pathologic Processes | |||||
| Prostatic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Saw Palmetto | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Permixon | |||||
| 6 | More general drug interventions related to this trial | ||||
| Androgen Antagonists | |||||
| Estrogen Antagonists | |||||
| Estrogen Receptor Modulators | |||||
| Hormone Antagonists | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| National Center for Complementary and Alternative Medicine (NCCAM) | |||||